P
AZN icon

Pitcairn’s AstraZeneca AZN Stock Holding History

Pitcairn’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,092
Closed -$1.24M – 52
2025
Q3 		$1.24M Sell
8,092
-1,306
-14% -$198K 0.1% 185
2025
Q2 		$1.31M Sell
9,398
-3,159
-25% -$443K 0.09% 215
2025
Q1 		$1.85M Buy
12,557
+2,409
+24% +$349K 0.11% 166
2024
Q4 		$1.33M Sell
10,148
-1,740
-15% -$244K 0.08% 218
2024
Q3 		$1.85M Sell
11,888
-420
-3% -$67.8K 0.11% 172
2024
Q2 		$1.92M Buy
12,308
+1,904
+18% +$287K 0.12% 161
2024
Q1 		$1.41M Buy
10,404
+4,092
+65% +$542K 0.09% 209
2023
Q4 		$850K Buy
6,312
+2,423
+62% +$315K 0.06% 272
2023
Q3 		$527K Buy
3,889
+752
+24% +$103K 0.04% 344
2023
Q2 		$449K Buy
3,137
+18
+0.6% +$2.65K 0.04% 387
2023
Q1 		$433K Buy
3,119
+778
+33% +$105K 0.04% 382
2022
Q4 		$317K Sell
2,341
-165
-7% -$20.7K 0.03% 447
2022
Q3 		$275K Buy
2,506
+639
+34% +$81.1K 0.03% 456
2022
Q2 		$247K Buy
+1,867
New +$245K 0.03% 498
2013
Q4 		– Sell
-5,109
Closed -$265K – 472
2013
Q3 		$265K Sell
5,109
-1,920
-27% -$96.4K 0.03% 386
2013
Q2 		$333K Buy
+7,029
New +$358K 0.04% 326

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pitcairn's AZN Position: Q4 2025 in Review

Pitcairn sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 8,092 shares — an estimated $1.24M sold.

Pitcairn first reported a position in AZN in Q2 2013 and held it in 16 quarters. The position peaked at $1.92M in Q2 2024. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Pitcairn reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 8,092 AstraZeneca shares in Q4 2025, an estimated $1.24M.
  • Pitcairn first reported a position in AstraZeneca in Q2 2013 and held it in 16 quarters.
  • Pitcairn's AstraZeneca position peaked at $1.92M in Q2 2024.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.